secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXICURE, INC. (XCUR)
CIK:        0001698530
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001698530-23-000010
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02, 7.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Exicure director resigns; Nasdaq extends equity compliance deadline, private placement closing by Feb 21
--------------------------------------------------------------------------------

- Director Jeffrey Cleland resigned from board and all committees effective Feb 10, 2023.
- Company non-compliant with Nasdaq independent director and audit committee requirements; cure period ongoing.
- Nasdaq granted extension to file 10-K by March 31 to evidence compliance with $2.5M equity rule; risk of delisting.
- Private placement of 3.4M shares at $1.60/share with CBI USA expected to close by Feb 21.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1698530/000169853023000010/0001698530-23-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1698530/000169853023000010/xcur-20230207.htm
  HTML page:      https://secwatch.observer/filing/0001698530-23-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer